Mycosis fungoides: Evaluation of immunohistochemical criteria for the early diagnosis of the disease and differentiation between stages

Lesional skin specimens from twenty-eight patients with mycosis fungoides were studied by evaluating immunohistochemical criteria, primarily with monoclonal antibodies. It was demonstrated that significant differences exist between the control and the premycotic-stage group in regard to the monoclon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Academy of Dermatology 1986-08, Vol.15 (2), p.237-245
Hauptverfasser: Tosca, Androniki D., Varelzidis, Anthony G., Economidou, Jane, Stratigos, John D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 245
container_issue 2
container_start_page 237
container_title Journal of the American Academy of Dermatology
container_volume 15
creator Tosca, Androniki D.
Varelzidis, Anthony G.
Economidou, Jane
Stratigos, John D.
description Lesional skin specimens from twenty-eight patients with mycosis fungoides were studied by evaluating immunohistochemical criteria, primarily with monoclonal antibodies. It was demonstrated that significant differences exist between the control and the premycotic-stage group in regard to the monoclonal antibodies BE1, BE2, and OKT9. The detection of specific antigenic determinants on the surface of cell populations early in the course of the disease seems to be of considerable value for the early diagnosis of the disease. Statistically significant differences were found between the premycotic stage and the plaque stage in regard to T lymphocytes, macrophages, OKT6 +, OKT4 +, OKT8 +, and BE2 + cells in the dermal infiltrate. Significant differences were also shown between the plaque and tumorous groups, concerning macrophages, T cells, and OKT9 + cells in the dermis, as well as epidermal dendritic cells. Differences between stages may supplement histologic data for the follow-up of the disease with or without treatment.
doi_str_mv 10.1016/S0190-9622(86)70163-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77007108</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962286701631</els_id><sourcerecordid>77007108</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-231bea0866177505b3b5ef4222566426d6099ff4fdedbca7c1917eb3d2d8bfbe3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS0EKkPhESp5gRAs0vonsRM2FaoKVGrFAlhbjn09Y5TYxXaK5gl4bTw_mi0rW_d-59g6B6ELSi4poeLqO6EDaQbB2PtefJB1xBv6DK0oGWQjZC-fo9UJeYle5fyLEDK0XJ6hM96xnrVshf4-bE3MPmO3hHX0FvJHfPukp0UXHwOODvt5XkLc-Fyi2cDsjZ6wSb5A8hq7mHDZAAadpi22Xq_D3q3qdmPrM-gMWAdb785BglD8wXqE8gcg4Fz0GvJr9MLpKcOb43mOfn6-_XHztbn_9uXu5tN9Y3g_lIZxOoImvRBUyo50Ix87cC1jrBOiZcIKMgzOtc6CHY2Whg5Uwsgts_3oRuDn6N3B9zHF3wvkomafDUyTDhCXrKQkRFLSV7A7gCbFnBM49Zj8rNNWUaJ2Bah9AWqXruqF2hegaNVdHB9YxhnsSXVMvO7fHvc61yhd0sH4fML6WlzLu4pdHzCoYTx5SCobD8GA9QlMUTb6_3zkH7nYpYY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77007108</pqid></control><display><type>article</type><title>Mycosis fungoides: Evaluation of immunohistochemical criteria for the early diagnosis of the disease and differentiation between stages</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tosca, Androniki D. ; Varelzidis, Anthony G. ; Economidou, Jane ; Stratigos, John D.</creator><creatorcontrib>Tosca, Androniki D. ; Varelzidis, Anthony G. ; Economidou, Jane ; Stratigos, John D.</creatorcontrib><description>Lesional skin specimens from twenty-eight patients with mycosis fungoides were studied by evaluating immunohistochemical criteria, primarily with monoclonal antibodies. It was demonstrated that significant differences exist between the control and the premycotic-stage group in regard to the monoclonal antibodies BE1, BE2, and OKT9. The detection of specific antigenic determinants on the surface of cell populations early in the course of the disease seems to be of considerable value for the early diagnosis of the disease. Statistically significant differences were found between the premycotic stage and the plaque stage in regard to T lymphocytes, macrophages, OKT6 +, OKT4 +, OKT8 +, and BE2 + cells in the dermal infiltrate. Significant differences were also shown between the plaque and tumorous groups, concerning macrophages, T cells, and OKT9 + cells in the dermis, as well as epidermal dendritic cells. Differences between stages may supplement histologic data for the follow-up of the disease with or without treatment.</description><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/S0190-9622(86)70163-1</identifier><identifier>PMID: 3528242</identifier><identifier>CODEN: JAADDB</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Antibodies, Monoclonal - immunology ; Biological and medical sciences ; Hematologic and hematopoietic diseases ; Histocytochemistry ; Humans ; Immunoenzyme Techniques ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Macrophages - pathology ; Medical sciences ; Mycosis Fungoides - diagnosis ; Mycosis Fungoides - immunology ; Mycosis Fungoides - pathology ; Naphthol AS D Esterase - analysis ; Neoplasm Staging ; Skin Neoplasms - diagnosis ; Skin Neoplasms - immunology ; Skin Neoplasms - pathology ; T-Lymphocytes - immunology ; T-Lymphocytes - pathology</subject><ispartof>Journal of the American Academy of Dermatology, 1986-08, Vol.15 (2), p.237-245</ispartof><rights>1986 American Academy of Dermatology, Inc.</rights><rights>1986 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-231bea0866177505b3b5ef4222566426d6099ff4fdedbca7c1917eb3d2d8bfbe3</citedby><cites>FETCH-LOGICAL-c389t-231bea0866177505b3b5ef4222566426d6099ff4fdedbca7c1917eb3d2d8bfbe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0190962286701631$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8787435$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3528242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tosca, Androniki D.</creatorcontrib><creatorcontrib>Varelzidis, Anthony G.</creatorcontrib><creatorcontrib>Economidou, Jane</creatorcontrib><creatorcontrib>Stratigos, John D.</creatorcontrib><title>Mycosis fungoides: Evaluation of immunohistochemical criteria for the early diagnosis of the disease and differentiation between stages</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><description>Lesional skin specimens from twenty-eight patients with mycosis fungoides were studied by evaluating immunohistochemical criteria, primarily with monoclonal antibodies. It was demonstrated that significant differences exist between the control and the premycotic-stage group in regard to the monoclonal antibodies BE1, BE2, and OKT9. The detection of specific antigenic determinants on the surface of cell populations early in the course of the disease seems to be of considerable value for the early diagnosis of the disease. Statistically significant differences were found between the premycotic stage and the plaque stage in regard to T lymphocytes, macrophages, OKT6 +, OKT4 +, OKT8 +, and BE2 + cells in the dermal infiltrate. Significant differences were also shown between the plaque and tumorous groups, concerning macrophages, T cells, and OKT9 + cells in the dermis, as well as epidermal dendritic cells. Differences between stages may supplement histologic data for the follow-up of the disease with or without treatment.</description><subject>Antibodies, Monoclonal - immunology</subject><subject>Biological and medical sciences</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Histocytochemistry</subject><subject>Humans</subject><subject>Immunoenzyme Techniques</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Macrophages - pathology</subject><subject>Medical sciences</subject><subject>Mycosis Fungoides - diagnosis</subject><subject>Mycosis Fungoides - immunology</subject><subject>Mycosis Fungoides - pathology</subject><subject>Naphthol AS D Esterase - analysis</subject><subject>Neoplasm Staging</subject><subject>Skin Neoplasms - diagnosis</subject><subject>Skin Neoplasms - immunology</subject><subject>Skin Neoplasms - pathology</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - pathology</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhS0EKkPhESp5gRAs0vonsRM2FaoKVGrFAlhbjn09Y5TYxXaK5gl4bTw_mi0rW_d-59g6B6ELSi4poeLqO6EDaQbB2PtefJB1xBv6DK0oGWQjZC-fo9UJeYle5fyLEDK0XJ6hM96xnrVshf4-bE3MPmO3hHX0FvJHfPukp0UXHwOODvt5XkLc-Fyi2cDsjZ6wSb5A8hq7mHDZAAadpi22Xq_D3q3qdmPrM-gMWAdb785BglD8wXqE8gcg4Fz0GvJr9MLpKcOb43mOfn6-_XHztbn_9uXu5tN9Y3g_lIZxOoImvRBUyo50Ix87cC1jrBOiZcIKMgzOtc6CHY2Whg5Uwsgts_3oRuDn6N3B9zHF3wvkomafDUyTDhCXrKQkRFLSV7A7gCbFnBM49Zj8rNNWUaJ2Bah9AWqXruqF2hegaNVdHB9YxhnsSXVMvO7fHvc61yhd0sH4fML6WlzLu4pdHzCoYTx5SCobD8GA9QlMUTb6_3zkH7nYpYY</recordid><startdate>19860801</startdate><enddate>19860801</enddate><creator>Tosca, Androniki D.</creator><creator>Varelzidis, Anthony G.</creator><creator>Economidou, Jane</creator><creator>Stratigos, John D.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19860801</creationdate><title>Mycosis fungoides: Evaluation of immunohistochemical criteria for the early diagnosis of the disease and differentiation between stages</title><author>Tosca, Androniki D. ; Varelzidis, Anthony G. ; Economidou, Jane ; Stratigos, John D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-231bea0866177505b3b5ef4222566426d6099ff4fdedbca7c1917eb3d2d8bfbe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Antibodies, Monoclonal - immunology</topic><topic>Biological and medical sciences</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Histocytochemistry</topic><topic>Humans</topic><topic>Immunoenzyme Techniques</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Macrophages - pathology</topic><topic>Medical sciences</topic><topic>Mycosis Fungoides - diagnosis</topic><topic>Mycosis Fungoides - immunology</topic><topic>Mycosis Fungoides - pathology</topic><topic>Naphthol AS D Esterase - analysis</topic><topic>Neoplasm Staging</topic><topic>Skin Neoplasms - diagnosis</topic><topic>Skin Neoplasms - immunology</topic><topic>Skin Neoplasms - pathology</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tosca, Androniki D.</creatorcontrib><creatorcontrib>Varelzidis, Anthony G.</creatorcontrib><creatorcontrib>Economidou, Jane</creatorcontrib><creatorcontrib>Stratigos, John D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tosca, Androniki D.</au><au>Varelzidis, Anthony G.</au><au>Economidou, Jane</au><au>Stratigos, John D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mycosis fungoides: Evaluation of immunohistochemical criteria for the early diagnosis of the disease and differentiation between stages</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>1986-08-01</date><risdate>1986</risdate><volume>15</volume><issue>2</issue><spage>237</spage><epage>245</epage><pages>237-245</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><coden>JAADDB</coden><abstract>Lesional skin specimens from twenty-eight patients with mycosis fungoides were studied by evaluating immunohistochemical criteria, primarily with monoclonal antibodies. It was demonstrated that significant differences exist between the control and the premycotic-stage group in regard to the monoclonal antibodies BE1, BE2, and OKT9. The detection of specific antigenic determinants on the surface of cell populations early in the course of the disease seems to be of considerable value for the early diagnosis of the disease. Statistically significant differences were found between the premycotic stage and the plaque stage in regard to T lymphocytes, macrophages, OKT6 +, OKT4 +, OKT8 +, and BE2 + cells in the dermal infiltrate. Significant differences were also shown between the plaque and tumorous groups, concerning macrophages, T cells, and OKT9 + cells in the dermis, as well as epidermal dendritic cells. Differences between stages may supplement histologic data for the follow-up of the disease with or without treatment.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>3528242</pmid><doi>10.1016/S0190-9622(86)70163-1</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0190-9622
ispartof Journal of the American Academy of Dermatology, 1986-08, Vol.15 (2), p.237-245
issn 0190-9622
1097-6787
language eng
recordid cdi_proquest_miscellaneous_77007108
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antibodies, Monoclonal - immunology
Biological and medical sciences
Hematologic and hematopoietic diseases
Histocytochemistry
Humans
Immunoenzyme Techniques
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Macrophages - pathology
Medical sciences
Mycosis Fungoides - diagnosis
Mycosis Fungoides - immunology
Mycosis Fungoides - pathology
Naphthol AS D Esterase - analysis
Neoplasm Staging
Skin Neoplasms - diagnosis
Skin Neoplasms - immunology
Skin Neoplasms - pathology
T-Lymphocytes - immunology
T-Lymphocytes - pathology
title Mycosis fungoides: Evaluation of immunohistochemical criteria for the early diagnosis of the disease and differentiation between stages
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T03%3A58%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mycosis%20fungoides:%20Evaluation%20of%20immunohistochemical%20criteria%20for%20the%20early%20diagnosis%20of%20the%20disease%20and%20differentiation%20between%20stages&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Tosca,%20Androniki%20D.&rft.date=1986-08-01&rft.volume=15&rft.issue=2&rft.spage=237&rft.epage=245&rft.pages=237-245&rft.issn=0190-9622&rft.eissn=1097-6787&rft.coden=JAADDB&rft_id=info:doi/10.1016/S0190-9622(86)70163-1&rft_dat=%3Cproquest_cross%3E77007108%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77007108&rft_id=info:pmid/3528242&rft_els_id=S0190962286701631&rfr_iscdi=true